173 related articles for article (PubMed ID: 33004063)
1. Mesenchymal stem/stromal cell quality control: validation of mixed lymphocyte reaction assay using flow cytometry according to ICH Q2(R1).
Nicotra T; Desnos A; Halimi J; Antonot H; Reppel L; Belmas T; Freton A; Stranieri F; Mebarki M; Larghero J; Cras A; Faivre L
Stem Cell Res Ther; 2020 Oct; 11(1):426. PubMed ID: 33004063
[TBL] [Abstract][Full Text] [Related]
2. Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation.
Piede N; Bremm M; Farken A; Pfeffermann LM; Cappel C; Bonig H; Fingerhut T; Puth L; Vogelsang K; Peinelt A; Marschalek R; Müller M; Bader P; Kuçi Z; Kuçi S; Huenecke S
Cells; 2023 Mar; 12(6):. PubMed ID: 36980191
[TBL] [Abstract][Full Text] [Related]
3. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
[TBL] [Abstract][Full Text] [Related]
4. Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use.
Torrents S; Del Moral AE; Codinach M; Rodríguez L; Querol S; Vives J
Immunol Res; 2023 Oct; 71(5):725-734. PubMed ID: 37120479
[TBL] [Abstract][Full Text] [Related]
5. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
[TBL] [Abstract][Full Text] [Related]
6. Qualification of a multidonor mixed lymphocyte reaction assay for the functional characterization of immunomodulatory extracellular vesicles.
Bremer M; Nardi Bauer F; Tertel T; Dittrich R; Horn PA; Börger V; Giebel B
Cytotherapy; 2023 Aug; 25(8):847-857. PubMed ID: 37097266
[TBL] [Abstract][Full Text] [Related]
7. Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction.
Prevosto C; Zancolli M; Canevali P; Zocchi MR; Poggi A
Haematologica; 2007 Jul; 92(7):881-8. PubMed ID: 17606437
[TBL] [Abstract][Full Text] [Related]
8. A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.
Bloom DD; Centanni JM; Bhatia N; Emler CA; Drier D; Leverson GE; McKenna DH; Gee AP; Lindblad R; Hei DJ; Hematti P
Cytotherapy; 2015 Feb; 17(2):140-51. PubMed ID: 25455739
[TBL] [Abstract][Full Text] [Related]
9. Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell.
Hansen SB; Højgaard LD; Kastrup J; Ekblond A; Follin B; Juhl M
Front Immunol; 2022; 13():1085312. PubMed ID: 36578497
[TBL] [Abstract][Full Text] [Related]
10. Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes.
Herzig MC; Christy BA; Montgomery RK; Cantu-Garza C; Barrera GD; Lee JH; Mucha N; Talackine JR; Abaasah IA; Bynum JA; Cap AP
Front Immunol; 2023; 14():1225047. PubMed ID: 37822938
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.
Engela AU; Baan CC; Litjens NH; Franquesa M; Betjes MG; Weimar W; Hoogduijn MJ
Clin Exp Immunol; 2013 Dec; 174(3):449-58. PubMed ID: 24028656
[TBL] [Abstract][Full Text] [Related]
12. A procedure for in vitro evaluation of the immunosuppressive effect of mouse mesenchymal stem cells on activated T cell proliferation.
Marinescu CI; Preda MB; Burlacu A
Stem Cell Res Ther; 2021 Jun; 12(1):319. PubMed ID: 34090507
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effects of human bone marrow mesenchymal stem cells and cord blood mononuclear cells on mixed lymphocyte response and PHA induction transformation].
Wei XF; Liu KY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):261-4. PubMed ID: 15228646
[TBL] [Abstract][Full Text] [Related]
14. Increased motility of mesenchymal stem cells is correlated with inhibition of stimulated peripheral blood mononuclear cells
Bertolo A; Pavlicek D; Gemperli A; Baur M; Pötzel T; Stoyanov J
J Stem Cells Regen Med; 2017; 13(2):62-74. PubMed ID: 29391751
[TBL] [Abstract][Full Text] [Related]
15. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease.
Amorim RM; Clark KC; Walker NJ; Kumar P; Herout K; Borjesson DL; Wang A
Stem Cell Res Ther; 2020 Jul; 11(1):304. PubMed ID: 32698861
[TBL] [Abstract][Full Text] [Related]
16. Post-thaw non-cultured and post-thaw cultured equine cord blood mesenchymal stromal cells equally suppress lymphocyte proliferation in vitro.
Williams LB; Tessier L; Koenig JB; Koch TG
PLoS One; 2014; 9(12):e113615. PubMed ID: 25438145
[TBL] [Abstract][Full Text] [Related]
17. Effect of menstrual blood-derived stromal stem cells on proliferative capacity of peripheral blood mononuclear cells in allogeneic mixed lymphocyte reaction.
Nikoo S; Ebtekar M; Jeddi-Tehrani M; Shervin A; Bozorgmehr M; Kazemnejad S; Zarnani AH
J Obstet Gynaecol Res; 2012 May; 38(5):804-9. PubMed ID: 22436017
[TBL] [Abstract][Full Text] [Related]
18. Clinical-scale expansion of mesenchymal stromal cells: a large banking experience.
Lechanteur C; Briquet A; Giet O; Delloye O; Baudoux E; Beguin Y
J Transl Med; 2016 May; 14(1):145. PubMed ID: 27207011
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of umbilical cord mesenchymal stem cells in the up-regulation of regulatory T cells by transforming growth factor β1 in systemic lupus erythematosus].
Lu L; Wang DD; Li X; Zeng XF; Sun LY
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):980-3. PubMed ID: 23886259
[TBL] [Abstract][Full Text] [Related]
20. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
